AnaptysBio (NASDAQ:ANAB), which is advancing an arthritis therapy similar to Eli Lilly's (NYSE:LLY) PD-1 agonist peresolimab, ...

NET PROFIT: Takeda is expected to post net profit of 50.0 billion yen, equivalent to $326.0 million, for the three months ended Sept. 30, according to a poll of analysts by Visible Alpha. That would ...

“If you notice a bright red colour, assuming you’re not a beet-eating champion, this is a sign of bleeding in your lower ...

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

Professional skaters Mark Hanretty and Brendyn Hatfield have announced that the 2025 series of Dancing On Ice will be their last. Hanretty, who is the longest-serving professional skater on the series ...

Celltrion USA today announced a late-breaking post hoc analysis of the pivotal LIBERTY studies of ZYMFENTRA®, during the ...

The study emphasises on the role of the p53 tumor suppressor gene in the pathogenesis of ulcerative colitis - an inflammatory bowel disease.

Prademagene zamikeracel (pz-cel) could be a new treatment for rare genetic disease recessive dystrophic epidermolysis bullosa (RDEB).

Complementary and alternative therapies for Crohn’s disease, like acupuncture and meditation, are useful approaches to managing symptoms in combination with a treatment plan.

Former two-weight UFC champion, Georges St-Pierre has claimed if he would have accepted an offer to fight Octagon alum, Nate Diaz during their respective ...

Children who are exclusively breastfed for the first six months may subsequently have a lower risk of suffering from Crohn 's ...

The FDA approval of Selarsdi 130 mg/26 ml in a single-dose vial for intravenous infusion expands the label to include ...